DexCom, Inc. (DXCM) NASDAQ

77.16

+1.5842(+2.10%)

Updated at September 16 10:44AM

Currency In USD

DexCom, Inc.

Address

6340 Sequence Drive

San Diego, CA 92121

United States of America

Phone

858 200 0200

Sector

Healthcare

Industry

Medical - Devices

Employees

10200

First IPO Date

April 14, 2005

Key Executives

NameTitlePayYear Born
Mr. Kevin Ronald SayerExecutive Chairman, Chief Executive Officer & President1.29M1958
Mr. Girish NaganathanExecutive Vice President & Chief Technology Officer423,9201978
Ms. Sadie M. SternExecutive Vice President & Chief Human Resources Officer550,8291975
Mr. Michael Jon BrownExecutive Vice President & Chief Legal Officer607,2361971
Mr. Jereme M. Sylvain CPAExecutive Vice President, Chief Financial Officer & Chief Accounting Officer621,9491980
Mr. Jacob Steven LeachExecutive Vice President & Chief Operating Officer693,1081978
Mr. Donald M. AbbeyExecutive Vice President of Global Business Services, IT, Quality & Regulatory Affairs766,8001967
Mr. Sean ChristensenVice President of Finance and Investor Relations0N/A
Mr. Matthew DolanExecutive Vice President of Strategy, Corporate Development & Dexcom Labs01982
Ms. Leverne MarshExecutive Vice President of Marketing0N/A

Description

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.